Antagonizing Bcl-2′s BH4 domain in cancer

Ítems similars

• BDA-366, a putative Bcl-2 BH4 domain antagonist, induces apoptosis independently of Bcl-2 in a variety of cancer cell models
  per: Vervloessem, Tamara, et al.
  Publicat: (2020)
• The BH4 Domain of Anti-apoptotic Bcl-XL, but Not That of the Related Bcl-2, Limits the Voltage-dependent Anion Channel 1 (VDAC1)-mediated Transfer of Pro-apoptotic Ca(2+) Signals to Mitochondria
  per: Monaco, Giovanni, et al.
  Publicat: (2015)
• BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis
  per: Vervliet, Tim, et al.
  Publicat: (2018)
• BH4 domain of Bcl-2 as a novel target for cancer therapy
  per: Liu, Zhiqing, et al.
  Publicat: (2015)
• The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor
  per: Rong, Yi-Ping, et al.
  Publicat: (2009)